Improved survival, rather than rising incidence, appears to be the main driver of increasing MS prevalence in France and ...

Among people with CIS, lower levels of certain small fatty molecules in the blood are associated with a higher relapse risk, ...

FDA clearance allows Imviva to test CTA313, an off-the-shelf CAR T-cell therapy, in progressive MS and other autoimmune ...

Columnist Desiree Lama says it takes so much effort to get through the day that she avoids most social activities these days.

Early trial data support quarterly dosing of an under-the-skin Briumvi formulation now being tested in Phase 3 for relapsing ...

PTSD is often associated with a single event, but for people with chronic illness, the trauma can be ongoing, says columnist Ben Hofmeister.

Using the newer drug Briumvi versus Aubagio led to significantly better outcomes for treatment-naïve people with relapsing MS ...

The FDA has placed a clinical hold on Quantum’s application seeking clearance to begin a Phase 2 trial testing Lucid-MS in ...

Using the approved multiple sclerosis therapy Kesimpta helps keep relapsing MS stable over time for most adults, a real-world ...

The MSAA is expanding its patient-centered research network to include more than 1,000 people with MS receiving care at 20 ...

Neurophet has entered a collaboration to advance software that uses AI to examine brain MRI scans for signs characteristic of ...

The National MS Society has released a new report detailing the lived experiences of people with MS and highlighting unmet ...